R R Weichselbaum
Overview
Explore the profile of R R Weichselbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
5785
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skowron K, Pitroda S, Namm J, Balogun O, Beckett M, Zenner M, et al.
Sci Rep
. 2016 Oct;
6:35854.
PMID: 27775025
Strategies to identify tumors at highest risk for treatment failure are currently under investigation for patients with bladder cancer. We demonstrate that flow cytometric detection of poorly differentiated basal tumor...
2.
Moormeier J, Williams S, Kaminer L, Ellis E, Garner M, Farah R, et al.
Leuk Lymphoma
. 2016 Jul;
5(4):243-8.
PMID: 27467846
Twenty-six patients with refractory or relapsed Hodgkin's disease were treated with high dose cyclophosphamide, BCNU, etoposide, and thiotepa followed by autologous hematopoietic stem cell rescue. Involved field radiotherapy was given...
3.
Michelle Xu M, Pu Y, Weichselbaum R, Fu Y
Oncogene
. 2016 Jul;
36(5):585-592.
PMID: 27425593
In advanced cancer, current conventional therapies or immunotherapies cannot eradicate all tumor cells for most patients. Integration of these two treatments for synergistic effects could eradicate more tumor cells and...
4.
Wightman S, Uppal A, Pitroda S, Ganai S, Burnette B, Stack M, et al.
Br J Cancer
. 2015 Jun;
113(2):327-35.
PMID: 26042934
Background: The CXCL10/CXCR3 signalling mediates paracrine interactions between tumour and stromal cells that govern leukocyte trafficking and angiogenesis. Emerging data implicate noncanonical CXCL10/CXCR3 signalling in tumourigenesis and metastasis. However, little...
5.
Voce D, Schmitt A, Uppal A, McNerney M, Bernal G, Cahill K, et al.
Oncogene
. 2014 Jul;
34(21):2807-13.
PMID: 25043302
NF-κB proteins play a central and subunit-specific role in the response to DNA damage. Previous work identified p50/NF-κB1 as being necessary for cytotoxicity in response to DNA alkylation damage. Given...
6.
Uppal A, Weichselbaum R, Posner M
Eur J Surg Oncol
. 2014 Apr;
40(9):1033-5.
PMID: 24703655
No abstract available.
7.
Seiwert T, Darga T, Haraf D, Blair E, Stenson K, Cohen E, et al.
Ann Oncol
. 2012 Oct;
24(3):769-76.
PMID: 23104721
Background: AdGV.EGR.TNF.11D (TNFerade™ Biologic) is a replication-deficient adenoviral vector expressing human tumor necrosis factor alpha (TNF-α) under the control of the chemoradiation-inducible EGR-1 promoter. TNF-α has been shown to function...
8.
Murley J, Baker K, Miller R, Darga T, Weichselbaum R, Grdina D
Free Radic Biol Med
. 2011 Sep;
51(10):1918-25.
PMID: 21945096
Manganese superoxide dismutase (SOD2)-mediated adaptive processes that protect against radiation-induced micronucleus formation can be induced in cells after a 2-Gy exposure by previously exposing them to either low-dose ionizing radiation...
9.
Advani S, Markert J, Sood R, Samuel S, Gillespie G, Shao M, et al.
Gene Ther
. 2011 May;
18(11):1098-102.
PMID: 21544094
Oncolytic viruses have been combined with standard cancer therapies to increase therapeutic efficacy. Given the sequential activation of herpes viral genes (herpes simplex virus-1, HSV-1) and the temporal cellular changes...
10.
Liauw S, Weichselbaum R, Rash C, Correa D, Al-Hallaq H, Pelizzari C, et al.
Technol Cancer Res Treat
. 2009 May;
8(3):201-6.
PMID: 19445537
Intensity modulated radiation therapy (IMRT) has achieved widespread use for prostate cancer; however, in relation to this use, outcomes studies are still relatively sparse. We report a single-institutional experience in...